thumbnail image
  • SCIENCE
  • CLINICAL TRIALS
  • PARTNERS 
    • PHARMA
    • PAYORS
    • HEALTH SYSTEMS
  • NEWS
  • OUR COMPANY 
    • AmDTx
    • OUR TEAM
    • CAREERS
  • CONTACT US
  • …  
    • SCIENCE
    • CLINICAL TRIALS
    • PARTNERS 
      • PHARMA
      • PAYORS
      • HEALTH SYSTEMS
    • NEWS
    • OUR COMPANY 
      • AmDTx
      • OUR TEAM
      • CAREERS
    • CONTACT US
    • SCIENCE
    • CLINICAL TRIALS
    • PARTNERS 
      • PHARMA
      • PAYORS
      • HEALTH SYSTEMS
    • NEWS
    • OUR COMPANY 
      • AmDTx
      • OUR TEAM
      • CAREERS
    • CONTACT US
    • …  
      • SCIENCE
      • CLINICAL TRIALS
      • PARTNERS 
        • PHARMA
        • PAYORS
        • HEALTH SYSTEMS
      • NEWS
      • OUR COMPANY 
        • AmDTx
        • OUR TEAM
        • CAREERS
      • CONTACT US
      • SCIENCE
      • CLINICAL TRIALS
      • PARTNERS
        • PHARMA
        • PAYORS
        • HEALTH SYSTEMS
      • NEWS
      • OUR COMPANY
        • AmDTx
        • OUR TEAM
          • OUR TEAM
          • CHIEF EXECUTIVE OFFICER
          • CHIEF TECHNOLOGY OFFICER
          • CHIEF OF CONTENT
          • CHIEF FINANCIAL OFFICER
          • VP PHARMACEUTICALS
          • ASSISTANT TO THE CEO
        • CAREERS
      • CONTACT US
        Go Back

        Dr. Annemiek Heijer, Healthcare & Insurtech

        LinkedIn
        LinkedIn
        More Details

        I graduated as a Medical Doctor in 1991 from Leiden University, the Netherlands. After 10 years as clinician and occupational doctor, I pivoted to General Manager of a Rotterdam Occupational Medicine Department, a post maintained for 8 years. I then spent six years running the R&D and Product Management Department at Zilveren Kruis Achmea, which is the largest private and public health insurance company in the Netherlands with 4.2 million customers. I also served on their Board of Directors during this period.

        As of 2016, I work for the Eurapco Alliance in Zurich, Switzerland, a partnership of mutual insurance companies across Europe. Recently, also I launch a Health and Innovation consulting firm in the Netherlands and now divide my time between the Netherlands, Switzerland and the rest of Europe working with health insurers, pharmaceutical companies and startups.

        • To prevent, measure, and treat mental illness, we develop digital theragnostics personalised with objective and scalable biomarkers.

          ↓↓↓
        • Proprietary Technology

          Our software uses facial photoplethysmography (PPG) and deep neural networks to personalise safe and effective treatments, while providing real time data on real world efficacy. The resulting gamified "measure-treat-measure" system has been clinically proven to reduce the risk of mental illness in cancer patients, as well as alleviate anxiety in young adults when compared to placebo in multiple clinical trials.

          Learn More
        • AI-based theragnostics every patient can access.

          Digitally-enabled pharmacotherapy, theragnostics and mental health endpoints.

          Pharma

          Giving policyholders access to clinically-validated mental wellness tools.

          Payors

          Supporting personalised healthcare on site and at home.

           

          Health Systems
        • Subscribe to the newsletter.

          Monthly updates on our progress tackling the world's mental health crisis.

          Subscribe

        CONTACT US

        TERMS OF USE

        PRIVACY POLICY

        Effective and accessible healthcare for every human.

          All Posts
          ×
          Cookie Use
          We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
          Learn More